50

Ambalal Sarabhai Enterprises LtdBOM 500009 Stock Report

Last reporting period 31 Mar, 2024

Updated 28 Oct, 2024

Last price

Market cap $B

0.012

Micro

Exchange

XBOM - Bombay Stock Exchange

500009.BO Stock Analysis

50

Avoid

Based on Eyestock quantitative analysis, 500009.BO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

21/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-83.7 %

Greatly overvalued

Market cap $B

0.012

Dividend yield

Shares outstanding

76.63 B

Ambalal Sarabhai Enterprises Ltd. is a pharmaceutical and electrical holding company, which engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparation (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in oncology, infertility and uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Private Limited is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited is a manufacturer of analytical and test and measuring instruments distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.

View Section: Eyestock Rating